12-10806332-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_023918.3(TAS2R8):c.649C>T(p.Leu217Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000849 in 1,613,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_023918.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R8 | NM_023918.3 | c.649C>T | p.Leu217Phe | missense_variant | 1/1 | ENST00000240615.3 | NP_076407.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R8 | ENST00000240615.3 | c.649C>T | p.Leu217Phe | missense_variant | 1/1 | NM_023918.3 | ENSP00000240615 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249086Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 134846
GnomAD4 exome AF: 0.0000862 AC: 126AN: 1461552Hom.: 0 Cov.: 39 AF XY: 0.0000839 AC XY: 61AN XY: 727064
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74412
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.649C>T (p.L217F) alteration is located in exon 1 (coding exon 1) of the TAS2R8 gene. This alteration results from a C to T substitution at nucleotide position 649, causing the leucine (L) at amino acid position 217 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at